Cargando…
The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients
HLA-B27 has an established relationship with the development of ankylosing spondylitis (AS). After reviewing the HLA-B genotype from 407 Chinese subjects (318 patients and 89 sex-matched controls), we found that 252 patients and 32 controls were HLA-B27(+) and that HLA-B(*)27:04 was the dominant HLA...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820707/ https://www.ncbi.nlm.nih.gov/pubmed/33490092 http://dx.doi.org/10.3389/fmed.2020.568790 |
_version_ | 1783639270677807104 |
---|---|
author | Wu, Xinyu Wu, Jialing Li, Xiaomin Wei, Qiujing Lv, Qing Zhang, Pingping Zheng, Xuqi Chen, Zena Cao, Shuangyan Tu, Liudan Gu, Jieruo |
author_facet | Wu, Xinyu Wu, Jialing Li, Xiaomin Wei, Qiujing Lv, Qing Zhang, Pingping Zheng, Xuqi Chen, Zena Cao, Shuangyan Tu, Liudan Gu, Jieruo |
author_sort | Wu, Xinyu |
collection | PubMed |
description | HLA-B27 has an established relationship with the development of ankylosing spondylitis (AS). After reviewing the HLA-B genotype from 407 Chinese subjects (318 patients and 89 sex-matched controls), we found that 252 patients and 32 controls were HLA-B27(+) and that HLA-B(*)27:04 was the dominant HLA-B27 subtype (N = 224). In all participants, HLA(*)27:04 homozygous were only detected in two patients. In the HLA-B27(+) group, HLA-B40 was observed in 51 cases and one control (p < 0.05, OR = 7.87, 95% CI 1.05–59.0); of these, the most genotype was HLA-B(*)27:04/B(*)40:01(N = 38). Two hundred thirty-nine patients' clinical information was recorded. Cases with HLA-B27/B46 had more peripheral joint involvement (OR = 3.95, 95% CI 1.77–8.79) in HLA-B27(+) AS. HLA-B(*)15:02 may be a significant risk element to peripheral joint involvement (p < 0.05) in HLA-B27(−) patients. Therefore, we believe HLA-B(*)40:01, HLA-B(*)46:01, and HLA-B(*)15:02 can be the test indicators for AS diagnostic value. |
format | Online Article Text |
id | pubmed-7820707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78207072021-01-23 The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients Wu, Xinyu Wu, Jialing Li, Xiaomin Wei, Qiujing Lv, Qing Zhang, Pingping Zheng, Xuqi Chen, Zena Cao, Shuangyan Tu, Liudan Gu, Jieruo Front Med (Lausanne) Medicine HLA-B27 has an established relationship with the development of ankylosing spondylitis (AS). After reviewing the HLA-B genotype from 407 Chinese subjects (318 patients and 89 sex-matched controls), we found that 252 patients and 32 controls were HLA-B27(+) and that HLA-B(*)27:04 was the dominant HLA-B27 subtype (N = 224). In all participants, HLA(*)27:04 homozygous were only detected in two patients. In the HLA-B27(+) group, HLA-B40 was observed in 51 cases and one control (p < 0.05, OR = 7.87, 95% CI 1.05–59.0); of these, the most genotype was HLA-B(*)27:04/B(*)40:01(N = 38). Two hundred thirty-nine patients' clinical information was recorded. Cases with HLA-B27/B46 had more peripheral joint involvement (OR = 3.95, 95% CI 1.77–8.79) in HLA-B27(+) AS. HLA-B(*)15:02 may be a significant risk element to peripheral joint involvement (p < 0.05) in HLA-B27(−) patients. Therefore, we believe HLA-B(*)40:01, HLA-B(*)46:01, and HLA-B(*)15:02 can be the test indicators for AS diagnostic value. Frontiers Media S.A. 2021-01-08 /pmc/articles/PMC7820707/ /pubmed/33490092 http://dx.doi.org/10.3389/fmed.2020.568790 Text en Copyright © 2021 Wu, Wu, Li, Wei, Lv, Zhang, Zheng, Chen, Cao, Tu and Gu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Wu, Xinyu Wu, Jialing Li, Xiaomin Wei, Qiujing Lv, Qing Zhang, Pingping Zheng, Xuqi Chen, Zena Cao, Shuangyan Tu, Liudan Gu, Jieruo The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients |
title | The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients |
title_full | The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients |
title_fullStr | The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients |
title_full_unstemmed | The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients |
title_short | The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients |
title_sort | clinical characteristics of other hla-b types in chinese ankylosing spondylitis patients |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820707/ https://www.ncbi.nlm.nih.gov/pubmed/33490092 http://dx.doi.org/10.3389/fmed.2020.568790 |
work_keys_str_mv | AT wuxinyu theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT wujialing theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT lixiaomin theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT weiqiujing theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT lvqing theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT zhangpingping theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT zhengxuqi theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT chenzena theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT caoshuangyan theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT tuliudan theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT gujieruo theclinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT wuxinyu clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT wujialing clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT lixiaomin clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT weiqiujing clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT lvqing clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT zhangpingping clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT zhengxuqi clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT chenzena clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT caoshuangyan clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT tuliudan clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients AT gujieruo clinicalcharacteristicsofotherhlabtypesinchineseankylosingspondylitispatients |